Navigation Links
Nephros Engages Joseph S. Cervia, M.D. as Strategic Consultant
Date:11/21/2011

ent with STERIS Corp. (NYSE: STE) related to its ultrafiltration technology.

Nephros has contracted with the Office of Naval Research to develop an advanced water purification system for military field use. Nephros's proprietary dual stage cold sterilization ultrafilter will form the basis of the portable system.

In response to a Request For Information (RFI) from the U.S. Army, Nephros submitted its UF-40 ultrafilter for consideration as part of the standard issue hydration pack for soldiers in the field.  Nephros has been informed by the U.S. Army Public Health Command that its UF-40 filter has been validated to meet the military's NSF P248 standard for emergency military operations as a microbiological water purifier.  Nephros believes that its UF-40 filter is the only stand-alone filter to date to have met the performance criteria of the NSF P248 standard without secondary disinfection steps.  The Army has not to date issued a Request For Proposal (RFP), and Nephros has no information regarding when or if an RFP applicable to the UF-40 ultrafilter may be put forth by the U.S. Army.

About Nephros, Inc.

Nephros, Inc., headquartered in River Edge, New Jersey, is a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification.

The Nephros hemodiafiltration (HDF) system is designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized by the irreversible loss of kidney function. The Nephros HDF system removes a range of harmful substances more effectively, and with greater capacity, than existing ESRD treatment methods, particularly with respect to substances known collectively as "middle molecules." These molecule
'/>"/>

SOURCE Nephros, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nephros Reports Third Quarter 2011 Financial Results
2. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
3. Nephros Reports Second Quarter 2011 Financial Results
4. Nephros Files 510(k) Application for Hemodiafiltration System
5. Nephros Receives 510k Approval to Market Additional Ultrafiltration Products
6. Nephros Reports First Quarter 2011 Financial Results
7. Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada
8. Nephros Reports 2010 Fourth Quarter and Full Year Financial Results
9. Nephros Announces Split Adjusted Trade Date
10. Nephros Announces Completion of Reverse Stock Split
11. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... 2014  Henry Schein, Inc. (NASDAQ: HSIC ... and services to office-based dental, animal health and medical ... Dental Supply, Inc., a leading full-service provider of dental ... Schein,s entrance into Japan , the ... to 28 the number of countries in which the ...
(Date:10/17/2014)... 2014  Training market researchers to spot and ... in today,s highly competitive global marketplace. As resources ... effectively and efficiently produce high performing analysts, regardless ... Effective training programs can help these ... internal clients by developing analysts who can drive ...
(Date:10/17/2014)... 2014 ... the addition of the  "China Interventional Cardiovascular ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... China impacted by accelerated ... concept, dietary habit, way of working and ...
Breaking Medicine Technology:Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2China Interventional Cardiovascular Device Industry Report 2014-2017 2China Interventional Cardiovascular Device Industry Report 2014-2017 3
(Date:10/20/2014)... October 20, 2014 Allegheny General Hospital’s ... that enables physicians to repair a damaged mitral valve ... MitraClip system, developed by Abbott Vascular , ... progressive and life-threatening condition in which the heart’s mitral ... flow backward from the heart’s left ventricle into the ...
(Date:10/20/2014)... 20, 2014 hc1.com today announced ... cloud solution that enables healthcare organizations of all ... healthcare-specific customer relationship management (“CRM”) solution. , Designed ... needs of the healthcare industry, the hc1 Healthcare ... and patients by combining healthcare CRM, HIPAA-compliant collaboration, ...
(Date:10/20/2014)... AttorneyOne.com, a recognized authority on law, update the website ... Sit and Slim II . , The FDA ... Sit and Slim II because it contains Sibutramine ... loss product on various websites and possibly in some retail ... safety reasons, can significantly increase blood pressure and/or pulse rate ...
(Date:10/20/2014)... OH (PRWEB) October 20, 2014 National Teen ... Chapter of the American Academy of Pediatrics (Ohio AAP, ... (NHTSA) in encouraging parents of teen drivers to talk to ... the road. , Motor vehicle crashes are the leading cause ... teen drivers involved in fatal crashes, and 859 (42%) of ...
(Date:10/20/2014)... Houston plastic surgeon Dr. Christopher ... of his innovative True Form Tummy Tuck® ... and faculty at The University of Texas Medical ... once a medical student. Patronella, who is a founding ... surgery practices in Texas, The Aesthetic Center for ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... Iowa, Oct. 30 Barack Obama today,stepped ahead of ... most,critical areas of foreign policy, the effort to eradicate ... this area, he pledged to,increase spending on global HIV/AIDS ... same time increasing overall foreign assistance spending to,$50 billion ...
... radiotherapy to treat breast cancer may, in some cases, ... toxic radiation as does the standard six weeks of ... because the short treatment, known as partial breast irradiation, ... through multiple beams, these beams can pass through the ...
... Vanda Pharmaceuticals,Inc. (Nasdaq: VNDA ), a ... clinical-stage product candidates for central,nervous system disorders, today ... II clinical trial evaluating VSF-173 in a,clinical model ... examined the effects of VSF-173 on a model ...
... PharmAthene, Inc., a leading,biodefense company specializing in the ... biological terrorism,announced today that it is scheduled to ... 9th Annual Healthcare Conference on Tuesday, November 6, ... Company will be David P.,Wright, President and Chief ...
... vitamin D levels and the overall risk of dying ... 30 in the Journal of the National Cancer ... with a decreased risk of colorectal cancer death. , ... vitamin D can reduce cancer mortality by decreasing cancer ...
... (NASDAQ: ANPI , TSX: ANP), a global ... participate in the CIBC 18th Annual,Healthcare Conference, which ... New York City. Tom Bailey, Angiotech Chief ... a 30-minute break-out session on Monday, November,5, beginning ...
Cached Medicine News:Health News:Obama Pledges Major Expansion of AIDS and Global Poverty Programs 2Health News:Normal tissue not spared in new forms of breast cancer radiotherapy 2Health News:Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties 2Health News:Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties 3Health News:Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties 4Health News:Study finds no connection between vitamin D and overall cancer deaths 2
The Precedent establishes a new generation of revision hip stems....
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Calcar replacement stems provide options for revision and trochanteric fractures. Revision hip surgery and trauma often require prosthetic designs that replace proximal medial calcar bone loss....
... materials contributes to successful outcomes for ... procedures and technique, the materials you ... your patients' outcomes, both short-term and ... Cross-Linked Polyethylene. MARATHON Polyethylene is the ...
Medicine Products: